13G/A filed by STROME MARK E
STROME MARK E and 5 other reporting persons reported 644,916 CUE shares, 8.5% of the class, as of 2026-07-14, in a 13G/A accepted by EDGAR 2026-10-08 11:37:06 UTC.
- Accession
- 0001213900-26-107721
- Filer
- CIK 919484
- Filed
- 2026-10-08
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- CUE · Cue Biopharma, Inc.
- Shares
- 644,916
- Percent of class
- 8.5%
- Event date
- 2026-07-14
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group STROME MARK E.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Mark E. Strome | IN | 1,674 | 643,242 | 1,674 | 643,242 | 644,916 | 8.5% |
| Strome Group, Inc. | CO | 0 | 643,242 | 0 | 643,242 | 643,242 | 8.48% |
| Strome Investment Management, LP | IA,PN | 0 | 643,242 | 0 | 643,242 | 643,242 | 8.48% |
| Strome Dynasty, LLC | OO | 0 | 50,000 | 0 | 50,000 | 50,000 | 0.66% |
| Strome Mezzanine Fund, LP | PN | 0 | 0 | 0 | 0 | 0 | 0% |
| Strome Mezzanine Fund II, LP | PN | 0 | 593,242 | 0 | 593,242 | 593,242 | 7.82% |